HIV-preventing Drug Holds up Under Study

Truvada, a daily pill that holds the hope of eliminating the risk of contracting HIV, appears to be living up to its promise.

In the first real-world study of the prescription drug, Kaiser researchers found no new HIV infections among the more than 650 people they followed over nearly three years, beginning just after the drug was approved by the U.S. Food and Drug Administration in 2012.

Please click here to see full article.